More on PHVS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (9.2 Score)

Upcoming Events

- Earnings (11/18/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Pharvaris (NQ:PHVS)
Delayed: 40.06 +2.55 (6.80%)
Prev. Close $37.51  
Open$38.13 
52 Wk High$ 
52 Wk Low$ 
Day High$40.60 
Day Low$37.47 
P/E N/A  
EPS$ 
Volume427,327 

Friends, Peers and Foes (?): ABBV, ACAD, ARWR, ASND, BCRX (more...)

Sep 10, 2026 04:49 PM Form 144 Pharvaris N.V. Filed by: Lesage Anne
Sep 10, 2026 07:06 AM Pharvaris B.V. (PHVS) PT Raised to $44 at Guggenheim
Sep 9, 2026 07:54 AM Pharvaris B.V. (PHVS) PT Raised to $62 at Morgan Stanley
Sep 9, 2026 07:27 AM H.C. Wainwright Reiterates Buy Rating on Pharvaris B.V. (PHVS)
Sep 9, 2026 07:23 AM Pharvaris B.V. (PHVS) PT Raised to $62 at RBC Capital
Sep 9, 2026 05:50 AM Pharvaris B.V. (PHVS) PT Raised to $65 at Wells Fargo
Sep 9, 2026 04:12 AM Pharvaris B.V. (PHVS) PT Raised to $79 at Citizens on Agent Trial Success
Sep 8, 2026 02:47 PM Pharvaris B.V. (PHVS) PT Raised to $75 at Oppenheimer
Sep 8, 2026 10:43 AM Pharvaris B.V. (PHVS) PT Raised to $65 at Cantor Fitzgerald
Sep 8, 2026 06:50 AM Pharvaris HAE drug hits 83% attack rate cut in phase 3 trial
View All Articles

Entities mentioned with PHVS

View All Entities